Clinical Trials Browser

Phase 2 × Gliosarcoma × Fenretinide × Clear all

NCT00075491 2013-01-24

Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme

Phase 2 Terminated

Brain Neoplasms, Glioblastoma, Gliosarcoma